Fig. 5.
Mean percentage change from baseline to 2 weeks (W), 4 weeks, 6 months (M), and 12 months in serum-corrected calcium level of (A) all subjects, (B) subjects based on renal function, and (C) subjects with or without prescription of a vitamin D analogue. *P < 0.05, **P < 0.01, and ***P < 0.001 versus baseline (Wilcoxon's signed-rank test). †P < 0.05, ††P < 0.01, and †††P < 0.001 versus group with a vitamin D analogue (Wilcoxon's rank-sum test).